Skip to content

Investigating the effectiveness of Ozone Hemotherapy on the respiratory condition of patients

Comparison of the Effectiveness of Ozone Hemotherapy on the Respiratory Condition of Patients with Sever Covid with the Control Group

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200504047298N4
Enrollment
60
Registered
2022-03-05
Start date
2022-03-15
Completion date
Unknown
Last updated
2022-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid 19. covid-19 diseaes

Interventions

Intervention 1: 30 patients are undergoing Hemotherapy with ozone for 10 sessions. The patient’s blood was taken at the first session to the amount of 120 cc and it is combined with 120 cc of gas. Whi

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Age over 18 years Getting infected with covid 19 disease (SARS_COV_2 PCR POSITIVE) Patients who are hospitalized in the course of the disease Spo2 under 90% On the CT scan of lung, the evidences of covid 19 are presented Not being admitted at the ICU, on the first visit, at the start of ozone therapy

Exclusion criteria

Exclusion criteria: Age less than 18 years Pregnancy Breastfeeding Intubated patient on the first visit at the start of ozone therapy Album below 3.5 Presence of underlying diseases (liver, kidney, hyperthyroidism, hypothyroidism, heart disease)

Design outcomes

Primary

MeasureTime frame
Respiratory status. Timepoint: Daily. Method of measurement: With pulse oximetry device.

Secondary

MeasureTime frame
Radiological changes in CT scan. Timepoint: Start of study, two weeks later. Method of measurement: Chest CT Scan.;Mortality rate. Timepoint: Start of study, two weeks later. Method of measurement: Patient's clinical condition.;Hospitalization rate in ICU. Timepoint: Start of study, two weeks later. Method of measurement: Evaluation of the patient's clinical condition.;Inflammatory factors. Timepoint: Start of study, two weeks later. Method of measurement: blood test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZeinab Siami

Tehran University of Medical Sciences

z.siami@abzums.ac.ir+98 21 4602 2136

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026